The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The Trent xwb has been the most successful engine ever launched.Hopefuly one day it will make up for the Trent 1000. Its basically saved RR civil engines. Hope we see lots of orders at Paris this week.
I can confirm this to be true
He's doing a
speech tomorrow.
AT last. An informative sensible post here. I have long stated that SNG will be £20-50 per share. This shows how it can happen.
All you have to do is be nice and say you've accidentally deleted the email with the details of the meeting and as you've only just started working for the company you don't want big boss to know. Most people will try to help in this instance.
Its like asking a postie which number Mr Potts lives at down the streeet. Thats confidential and they cannot tell you. But if there is no Mr Potts the Postie can tell you that no one of that name lives in this street. Just like a hotel informing me that no one linked to SNG has a room booked.
Manifestly wrong. You did indeed correct it but you did your due diligence far too late! :-)
Manifestly wrong.
Synaigen? After how long have you been here!!
I've just called the Southampton harbourside Hotel. They've never heard of RM.
PJX Savvy investors know how to spell 'lose'.
I'm still waiting for the new buyer to announce. I thought they would announce last month but they;ve dragged their heels.
I've always said this could go to £25-50 though I think £15-25 is more realistic £75 is beyond life changing.
I think a few people are startng to be concerned about staying in SNG. Just remember what I said recently about buying a dog and training it to bite you should you go near the sell button! Nothing has changed apart from more people catching Covid. SNG is still in the race and now on the final straight. You've got to be in it to win it remember.
BIGJONNY wrote
The treatment showed a 79% reduction in deaths in the Phase 2 trial.
This is not true. Nobody died who took SNG001. I believe 3 people died who took the placebo.
SNG001 was 79% more effective at reducing hospital stays in ICU which cost £2000 a day thus making SNG001 cost effective.
Nobody so far has been reported as dying after being treated with SNG001. LIves continue to be lost daily because SNG001 is not out there where it should be and this needs to change.
It comes down to Small size companies and being risk adverse. The shares have risen since they bought and the current value is above their weighting for small companies etc.
Now that was a prediction 3 minutes before the RNS!
More to come shortly.
As I said a short while ago there are other buyers out there who will release and RNS this side of the New Year. Polar may have sold stupidly but there are smart buyers about.
Lockwood Advisors have 4.6m shares (2.3%) I am hoping they buy more.
Today is 35 days since full recruitment. Lets hope for news soon.